In this paper, we consider a model for the population kinetics of human tumor cells in vitro, differentiated by phases of the cell division cycle and length of time within each phase. Since it is not easy to isolate the effects of cancer treatment on the cell cycle of human cancer lines, during the process of radiotherapy or chemotherapy, therefore, we include the spatial effects of cells in each phase and analyse the extended model. The extended model is not easy to solve analytically, because perturbation by cancer therapy causes the flow cytometric profile to change in relation to one another. Hence, making it difficult for the resulting model to be solved analytically.
INTRODUCTION
It is a well known fact that vascular tumors are a highly diverse group of aberrant growths and they are relatively abundant in the human population, with infantile hemangiomas being the most common tumor in children and cavernous hemangiomas affecting approximately one in every one hundred people see [2] and the references therein. Thus, apart from our previous work reported in [18, 19, 20, 21] on tumors, we feel that it is essential for us as researchers to understand that genetic differences between people lead to differences in susceptibility. Since tumors develop in different organs and tissues of a body, then this should imply that a genetic heterogeneity among cancer cells, the cellular heterogeneity of the tumor tissue underlie a phenotype heterogeneity of the disease and cancer cells in a tumor are not all identical, but form different clones, defined as sets of cancer cells that share a common genotype [31] . Therefore, in our views, it is also very important to study dynamics for the kinetics of a population of cells differentiated by phases of the cell division cycle such as the ones presented by Jackiewicz et al., [12] as a way toward avoiding incorrect treatment decisions especially, if a biopsy sample is not representative of other parts of the tumor.
On the other hand, it is understood that even in the simplified environment of the laboratory with modern techniques and/or technology, it is not always possible to isolate the effects of cancer treatment on the cell cycle of human cancer cell lines. Therefore, it is important to mentioned some of the work done in the direction of understanding cancer cells from the cells cycle point of view. Thus, we highlight few work done in this direction of the studies. These are for instance Giotti et al., in [11] mentioned that cell division is central to the physiology and pathology of all eukaryotic organisms and in [4, 7, 8] , have considered the in-vitro model of cancer therapies that target the cellular mechanisms of growth, division and death in all or some stages of the cell cycle. Thus, our first aim in this paper is to include the spatial distribution of each phase for the model derived in [4] and presented in [12] . The model in [12] is given as follow, The term I(x,t; T S ) denotes cells that have been T S hours in DNA synthesis and are ready to be transferred to G 2 phase, which is also referred to as a delay term and its derivation is explained in [4] . However, I(x,t; T S ) denotes the solution of the diffusion equation
at time τ S = T S , where τ S is the time denoting the time spent by cells in DNA synthesis or Sphase. The analytical solution (with appropriate initial conditions and a zero flux boundary condition) is obtained by using Laplace transform techniques and Greens functions in [12] .
Thus, it reads
where γ(T S , x, y) denotes a weight function given by
In equation (3) γ denotes a Greens function whereas, ν term arises due to the zero flux boundary condition.
The system (1) is incomplete without initial and boundary conditions. These conditions, which are chosen according to experimental evidence [12] , take the form of
and the boundary condition
The initial DNA content of cells in the G 1 phase is chosen as a Gaussian distribution with relative mean DNA content at x = 1 equal to a 0 , and variance θ 2 0 . This variance is chosen sufficiently small so that the extension of G 1 (x, 0) into the in-feasible region x < 0 is of no significance. In [12] a numerical methods are constructed to solve (1) supplemented by the initial conditions in equation (4) and the general boundary conditions of the form of
with any real values α and β , where the parameter β was chosen according to the experimental data provided in [5] .
We can see that the system in equation (1) is a semi-system of integro-delayed partial differential equation (IDPDE). Thus, in order to have a complete understanding of the population kinetics of the human tumor cells, it is very important to include the spatial effects of all the cells in each phase, rather only consider the spatial effects of one phase and ignore the other effects of the other three phases. Consequently, mathematical analysis of the extended model is also vital to justify the understanding of the population kinetics of human tumor cells, when one present the experimental results. Therefore, our first aim in this paper, is to extend the model in It is a well known fact that explicit methods such as the explicit finite difference methods (EFDMs), solve differential equations with low computational cost, within very small stability regions, which in turn implies severe restrictions on meshes sizes, which are required in order to achieve the desired results. Therefore, implicit finite difference methods (IFDMs) are more favored to solve differential equations, because of their wider stability regions as compared to the EFDMS [9] . Thus, our second aim in this paper, is to solve the extended model. Thus, we develop an efficient numerical method for solving the extended model with respect to the qualitative features of the original model.
Thus, extending the IDPDE in equation (1), we have
where, D G 1 , D G 2 , D M denote the dispersion coefficient of G 1 , G 2 and M cells in each phase, 0 <
x < L and t > 0, subject to the initial data as given in equation (4) and the boundary conditions
where, ν, χ k , (k = 1, 2) denote an outward normal vector, and positive constants, whereas the
are assumed to satisfy the compatibility conditions [26] ,
and
Under the assumptions in (9-10) the extended model in equation (7) with the initial and boundary conditions in (8) has a unique solution [3] .
The rest of the paper is arranged as follow. In Section 2, we carry out mathematical analysis of the model, whereas in Section 3, we derive and analyse the numerical method. Section 4 deals with the implementation of our numerical method, presentation of our numerical results and we conclude the paper with Section 5.
MATHEMATICAL ANALYSIS OF THE MODEL
At the steady states the model in equation (7) becomes
From the first, third and fourth equations in (11) we obtain the following solutions for the corresponding homogeneous part
where, c g11 , c g12 , c g21 , c g22 , c m1 , c m2 are non-negative constants. However, for the DNA synthesis or Sphase steady state, we see that the null space is given by
of which the auxiliary equation to the equation (13) is
which implies that the solution to the auxiliary equation in (14) is
which in turn, implies that the solution to the second order differential equation in (13) is
where, from the given general boundary conditions in (8) , we find that
so that
.
At x = L, the DNA synthesis or Sphase is prescribed as
Substituting the value of B in (19) into equation (19) we obtain
This implies that the solution of the DNA synthesis or Sphase steady state, through the equation
Combining the equation in (21) with the steady-state solutions in equation (12), we have the
The steady point E , enables us to present the behavior of the density of cells in each phase.
Moreover, the steady state for the DNA synthesis or Sphase enables us to locate the boundary layer which is a result of perturbation by cancer therapy [12] . Thus, since the singularly perturbation occurs only during the DNA synthesis or Sphase, then it suffices to locate the layer by considering the solution to the steady state of the DNA synthesis or Sphase in equation (21) .
Thus, following [24] and the references there in, we see that 
then, the layer is located on the right-end of the interval, near x = L. This implies that, we are now in the position of deriving our numerical method.
DERIVATION AND ANALYSIS OF THE NUMERICAL METHOD
In this section, we describe the derivation of the fitted operator finite difference numerical method (FOFDM) for solving the G 1 phase, G 2 phase and metosis or Mphase in equation (7) and non-standard finite difference method (NSFDM) for solving the DNA synthesis or Sphase in equation (7) . We first determine an approximation to the derivatives of the functions G 1 (t, x), G 2 (x,t) and M(t, x) with respect to the spatial variable x.
Let N x be a positive integer. Discretize the interval [0, L] through the points
note the numerical approximations of G 1 (t, j), G 2 (t, j), M(t, j), then we approximate the second order spatial derivative by
where,
We see that φ G 1 → ∆x as ∆x → 0, φ G 2 → ∆x as ∆x → 0 and φ M → ∆x as ∆x → 0.
Let N t be a positive integer and ∆T = T /Nt where 0 < t < T . Discretizing the time interval
[0, T ] through the points
where, t n+1 − t n = ∆t, n = 0, 1, . . . , (t N t − 1).
We approximate the time derivative at t n by
where we see that ψ G 1 → ∆t as ∆t → 0, ψ G 2 → ∆t as ∆t → 0 and ψ M → ∆t as ∆t → 0.
Next we develop the numerical method to solve the DNA synthesis or Sphase in equation (7) .
Since the FOFDM and SFDM fail to capture the hyperbolic nature of the advection-diffusionreaction PDEs, below we follow the development in [16] to derive the NSFDM for the equation modeling the DNA synthesis or Sphase in equation (7) . We proceed as follow. Let S j (t) denote the numerical approximations of S(t, j), then using the following sub-equations of the equation modeling the DNA synthesis or Sphase in equation (7) ∂ S(x,t)
then the exact finite difference schemes for the two sub-equations in equation (27) are
, a scheme for an ODE,
where (φ 1 ) S (∆t) = (1 − exp(−µ S ∆t))/µ S and (φ 2 ) S (∆x) = (1 − exp(− g∆x ε )). Combining the exact finite difference schemes in equation (28) and avoid the condition g∆t = ∆x, we obtain the NSFDM for the DNA phase as
where ϕ(∆x) = gφ S ( ∆x g ) ε∆x g (φ 2 ) S (∆x). We see that φ S → ∆x as ∆x → 0. Similarly for ϕ(∆x). The denominator functions in equations (24) , (26) and (28) are used explicitly to remove the inherent stiffness in the central finite derivatives parts and can be derived by using the theory of nonstandard finite difference methods, see, e.g., [15, 22, 23] and references therein.
Combining the equation (24) for the spatial derivatives with the equation (26) for time derivatives and with equation in (29) , we obtain the system of FOFDM-NSFDM as
The system in equation (30) can further be simplified as
The system in equation (31) can be written as a tridiagonal system given by
where, j = 1, . . . , x N x − 1, n = 0, . . . ,t N t − 1 and
Thus, in view of equation (32), we see that the local truncation errors ((ς G 1 ) n j , (ς S ) n j , (ς G 2 ) n j , (ς M ) n j are given by
where t n−1 ≤ ζ ≤ t n+1 , x j−1 ≤ ξ ≤ x j+1 and by [27] we have
Using (35) and (36) in (34), we obtain
Hence, we obtain the following results.
. . L, n = 1, 2, . . . T be the approximate solutions to (7) , obtained using the FOFDM-NSFDM with (G 1 ) 0
Then there exists Ξ G 1 , Ξ S , Ξ G 2 , Ξ M independent of g, ε, the step sizes ∆t and ∆x such that
This shows that our FOFDM-NSFDM are unconditionally stable.
NUMERICAL RESULTS AND DISCUSSIONS
Setting D G 1 = 10 −4 , D G 2 = 10 −4 , D M = 10 −7 , L = 5, T = 1, x N x = t N t = 20 and , we present our numerical solutions in Figure 1 (for ε = 0.001), Figure 2 (for ε = 0.01), Figure 3 (for ε = 0.1) using the parameter values [4] in Table 1 . 
In Figure 1(a) , we see that as time grows the density of cells are increasing within the range of approximately of x ∈ (0, 1.5), then for the values of x ∈ (1.5, 5), the profile presents that there are no more cells available for G 1 phase.
In Figure 1 (b), we see that as time grows the density of cells form a peak which is increasing within the range of approximately of the values of x ∈ (0, 1.5), then for the values of x ∈ (1.5, 5)
the density of cells converges to its low positive steady state.
In Figure 1(c) , we see the contrary to the profiles of the two previous profiles. That, as time grows the density of cells grows exponentially for x ∈ (0, 1.5), till they reach a positive steady state for x ∈ (1.5, 5). The profile of this phase presents that all cells are well and active for next interactions.
In Figure 1(d) , we see similar development compare to the interactions in the Mphase, that as time grows the density of cells grows exponentially for the values of x ∈ (0, 1.5), till they reach a positive steady state for x ∈ (1.5, 5). The profile of this phase presents that all cells are well and active for the next interaction.
The remaining two figures, Figure 2 and Figure 3 , we have the same profiles as in Figure 1 ,
for different values of ε ∈ (0, 1).
CONCLUSION
In this paper, we extended the model for population kinetics of human tumor in vitro, with the aim to contribute toward the understanding of cells cycle in each phase. This is very essential toward healing cancer as a dreadful disease, since in [12] categorically mentioned that even in the simplified environment of the laboratory with modern technology it is not always possible to isolate the effects of cancer treatment on the cell cycle of human cancer lines. Thus, in view of our numerical results, we see that for the values of 0 < ε <<< 1 and g >>> 1 our numerical 
